NANobuyuki Amino

Nobuyuki Amino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nobuyuki Amino has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A novel PROP1 gene mutation (157delA) in Japanese siblings with combined anterior pituitary hormone deficiency

    by Ke-Ita Tatsumi, Kiyoshi Kikuchi, Kumi Tsumura, Nobuyuki Amino

    The majority of cases of combined anterior pituitary hormone deficiency (CPHD) reported in Japanese patients have PIT1 abnormality. This study describes for the first time a homozygous mutation of the PROP1 gene in two Japanese siblings with CPHD born to consanguineous parents. Two siblings were growth retarded at 3 years of age and developed hypothyroidism. Pituitary function tests showed combined deficiency of GH, TSH, PRL and gonadotrophins. The size of their pituitary glands decreased with age, as demonstrated by magnetic resonance imaging (MRI). The PROP1 gene was analysed by polymerase chain reaction (PCR) followed by direct sequencing. Both children were homozygous for a novel single base deletion at codon 53 (157delA), while their parents were heterozygous. This mutation, if translated, predicts the production of a protein lacking the paired-like homeodomain required for DNA binding, suggesting that the mutation was the direct cause of CPHD in these patients. 157delA is the first reported Japanese PROP1 gene mutation. In Japan, PROP1 abnormality appears to be a less frequent cause of CPHD than does PIT1 abnormality, whereas PROP1 abnormality predominates in CPHD patients of Caucasian and European origin.


    • 1 January 2004
      • Vol. 52  (1) , 44-50

    [Differential diagnosis of hepatitis: development of new laboratory tests for autoimmune hepatitis and progress in pathophysiology].

    by Nobuyuki Amino, Masahiro Kimura, Susumu Tanaka, Yukiko Izumi, Masaki Ikemoto, Ke-Ita Tatsumi, Toru Takano, Yoh Hidaka

    Liver dysfunction has been found in 8.1% of postpartum women in the general population. This dysfunction was speculated to be developed by postpartum aggravation of subclinical autoimmune hepatitis. Therefore, we developed two methods for detection of autoantibodies to liver-specific antigens: an ELISA for anti-liver-specific arginase antibodies, and a highly sensitive radioligand assay for anti-CYP2D6 antibodies. Basic examinations of dilution curve, inhibition study and reproducibility were satisfactory for clinical application in both assays. Anti-arginase antibodies and anti-CYP2D6 antibodies were found in 28.6% and 42.6% of patients with autoimmune hepatitis, respectively. There was no correlation between the two autoantibodies and thus, combined use of these antibodies detects 55.3% of autoimmune hepatitis. Autoimmune hepatitis exists frequently when we include mild cases.

    • 1 January 2004
      • Vol. 52  (1) , 62-6

    [Molecular-based diagnosis of thyroid carcinoma: germ-cell carcinogenesis and aspiration biopsy nucleic acid diagnosis(ABND)].

    by Toru Takano, Nobuyuki Amino

    Recent data have shown the existence of specific changes in mRNAs in thyroid carcinomas. It has not been clarified, however, why these changes clearly distinguish benign tissues from carcinomas, while genomic alternation such as mutations in the RAS or P53 genes do not. Further, the widely believed hypothesis, multi-step carcinogenesis, does not explain some clinical and experimental evidence of thyroid carcinomas. Considering these facts, we propose a new idea for thyroid carcinogenesis called "germ-cell carcinogenesis", in which cancer cells are derived from the remnant of fetal thyroid germ cells(thyroblasts) instead of normal thyroid follicular cells. Utilizing such mRNAs, we have established a new method for preoperative molecular-based diagnosis of thyroid carcinomas, Aspiration Biopsy Nucleic Acid Diagnosis(ABND). ABND allows us to perform preoperative nucleic acid analyses of the tumors by extracting RNAs or DNAs from tumor cells obtained by fine needle aspiration biopsies(FNABs). Pathological diagnosis of thyroid follicular carcinoma is quite difficult, and the establishment of preoperative molecular-based diagnosis of follicular carcinoma has been long expected. We found that quantification of the trefoil factor 3(TFF3)/galectin-3 mRNA ratio in thyroid tumor cells is a useful tool for distinction between follicular adenomas and carcinomas. Because ABND can be performed without any severe invasion to the patients, in the near future, when more reliable systems of quantitative RNA analysis have been developed, ABND will probably become one of the standard tests for preoperative diagnosis of thyroid carcinoma.

  • No Increase of Blocking Type Anti-Thyrotropin Receptor Antibodies During Pregnancy in Patients with Graves’ Disease

    by Nobuyuki Amino, Yukiko Izumi, Yoh Hidaka, Keiko Takeoka, Yukiko Nakata, Ke-Ita Tatsumi, Atsuo Nagata, Toru Takano

    Serial changes in serum levels of anti-TSH receptor antibodies were examined during and after pregnancy in six patients with Graves' disease receiving no or minimal maintenance doses of antithyroid drugs. During pregnancy, serum levels of TSH-binding inhibitory Igs (P < 0.001) and thyroid-stimulating antibodies (TSAbs) (P < 0.01) decreased gradually but increased after delivery in all patients. Activities of thyroid-stimulation blocking antibodies (TSBAbs) were lower than the cut-off value in early pregnancy, and values significantly decreased in four patients during pregnancy. The other two patients showed no significant change during pregnancy. In contrast, TSBAb levels increased significantly (P < 0.01) after delivery in all patients. We found that activities of TSH-binding inhibitory Igs, TSAb, and TSBAb decrease during pregnancy and increase after delivery, suggesting that amelioration of Graves' disease during pregnancy is induced by decrease of TSAb but not by the appearance of TSBAb.


  • Possible Induction of Graves' Disease and Painless Thyroiditis by Gonadotropin-Releasing Hormone Analogues

    by Nobuyuki Amino, Yoh Hidaka, Toru Takano, Ke-Ita Tatsumi, Yukiko Izumi, Yukiko Nakata

    Prolonged administration of gonadotropin-releasing hormone (GnRH) analogues induce a decrease in serum estrogen level, which may aggravate subclinical or mild autoimmune thyroid disease. Two patients developed Graves' thyrotoxicosis in association with an increase in anti-thyrotropin (TSH) receptor antibody activities at 4 months after initiation of buserelin acetate. GnRH analogue therapy was discontinued at the time of diagnosis but it took more than 2 years of methimazole therapy to obtain remission of Graves' disease. Another patient developed painless thyroiditis in association with an increase in antithyroid microsomal antibodies at 4 months after initiation of leuprolide acetate. These results indicate that GnRH analogues possibly induce clinical onset of Graves' thyrotoxicosis or destruction-induced thyrotoxicosis. Clinicians should be aware of this phenomenon. All patients who are to receive GnRH analogue therapy should be examined for antithyroid antibodies and family history of autoimmune thyroid disease, and should be followed accordingly.


  • Association of Seasonal Allergic Rhinitis is High in Graves' Disease and Low in Painless Thyroiditis

    by Nobuyuki Amino, Yoh Hidaka, Toru Takano, Yukiko Izumi, Ke-Ita Tatsumi, Yukiko Nakata

    Hashimoto's thyroiditis is thought to be a T-helper cell type 1 (TH1)-dependent disease, but it is not clear whether Graves' disease is T-helper cell type 2 (TH2)-predominant or not. TH1-predominant diseases are infrequently and TH2-predominant diseases are frequently associated with allergic diseases. We examined the prevalence of seasonal allergic rhinitis to Japanese cedar pollen, a typical TH2-associated disease, in patients with Graves' disease (n = 126), painless thyroiditis (n = 46) and Hashimoto's thyroiditis (n = 88), and compared them to healthy controls (n = 766). Gender and age distribution were not different among patient groups and healthy controls, except for the higher age of patients with Hashimoto's thyroiditis. The prevalence of seasonal allergic rhinitis was significantly high in patients with Graves' disease (42.9%, p < 0.05) and low in patients with painless thyroiditis (13.0%, p < 0.01) but was not different in patients with Hashimoto's thyroiditis (26.1%) compared to that of healthy controls (32.6%). When patients with painless thyroiditis were included in Hashimoto's thyroiditis group, the prevalence of seasonal allergic rhinitis was 21.6% and significantly different from that of healthy controls (p < 0.05). These data indicate that Graves' disease is TH2 predominant and painless thyroiditis is a TH1-predominant disease. Our findings suggest that the shift from TH2 toward TH1 immunogenesis may be important for achieving earlier remission of Graves' disease.


    • 1 February 2003
      • Vol. 51  (2) , 152-7

    [Aspiration biopsy RNA diagnosis].

    by Toru Takano, Nobuyuki Amino

    Recent advances in molecular-based techniques, especially RNA analyses such as differential display, serial analysis of gene expression(SAGE) and DNA arrays, have enabled us to detect the specific changes in mRNA in cancer tissues rapidly and easily. We have established a new method of preoperative molecular-based diagnosis of thyroid carcinomas, one of the most common cancers in females. This technique, Aspiration Biopsy RNA Diagnosis, ABRD, allows us to perform preoperative RNA analysis of the tumors by extracting RNA from tumor cells obtained by fine needle aspiration biopsies(FNABs). For example, by ABRD detection of oncofetal fibronectin or calcitonin mRNA in FNABs, three types of thyroid carcinomas, papillary, anaplastic and medullary carcinomas, were accurately diagnosed preoperatively without the help of cytological or pathological examinations by a skillful pathologist. Further, by real-time monitoring RT-PCR measuring the expression levels of these cancer-specific mRNAs, a fully automated system was established. Because ABRD can be performed without any severe invasion to the patients, in the near future, when more reliable systems of quantitative RNA analysis are developed, ABRD will probably become one of the standard tests for preoperative diagnosis of cancer.

  • Quantitative Analysis of Osteonectin mRNA in Thyroid Carcinomas.

    by Toru Takano, Yukiko Hasegawa, Akira Miyauchi, Fumio Matsuzuka, Hiroshi Yoshida, Kanji Kuma, Nobuyasu Hayashi, Shoji Nakamori, Nobuyuki Amino

    Our recent study of the gene expression profile in thyroid carcinoma showed an overexpression of osteonectin mRNA, an extracellular matrix protein, in an anaplastic carcinoma. To confirm this, we measured the expression levels of osteonectin mRNA in 84 thyroid normal and tumor tissues, including five anaplastic carcinomas by realtime quantitative reverse-transcription PCR. Increased expression of osteonectin mRNA was observed in anaplastic carcinoma tissue. However, in five anaplastic carcinoma cell lines, no increase was observed in the expression levels of osteonectin mRNA. These findings suggest the possibility that increased expression of osteonectin mRNA in anaplastic carcinoma tissue may be due to its overexpression in stromal cells, but not in anaplastic carcinoma cells.


  • Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis

    by Masahiro Kimura, Ke-Ita Tatsumi, Hisato Tada, Yukiko Izumi, Akira Kaneko, Michio Kato, Manabu Masuzawa, Masaki Ikemoto, Yoshiyasu Yabusaki, Yoh Hidaka, et al.